KalVista Pharmaceuticals, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Apr'25
Apr'24
Apr'23
Apr'22
Apr'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-171.00
-185.00
-135.00
-92.00
-82.00
-46.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
15.00
15.00
7.00
-12.00
8.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-81.00
-152.00
-89.00
-75.00
-78.00
-30.00
Cash Flow from Investing Activities
18.00
91.00
-84.00
41.00
57.00
-147.00
Cash Flow from Financing Activities
162.00
159.00
150.00
58.00
1.00
212.00
Net Cash Inflow / Outflow
97.00
100.00
-24.00
25.00
-19.00
34.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-1.00
2.00
-1.00
1.00
-1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of KalVista Pharmaceuticals, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-171.4185
-129.468
-42.00
-32.40%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0.954
-5.459
5.00
117.48%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-81.621
-113.367
32.00
28.00%
Cash Flow from Investing Activities
18.684
-148.031
166.00
112.62%
Cash Flow from Financing Activities
162.641
247.661
-85.00
-34.33%
Net Cash Inflow / Outflow
97.873
-13.737
110.00
812.48%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-1.831
0
-1.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
Not Applicable: The company has declared_date for only one period
Dec'25
Change(%)
Cash Flow from Operating Activities
-81.62
NA
NA






